LakeShore Biopharma Co., Ltd (LSBCF)

Revenue by Product

Financials in millions USD. Fiscal year is April - March.

Year Ending	Mar 31, 2024	Mar 31, 2023	Dec 31, 2021	Dec 31, 2020
Biopharmaceutical Products	85.19M
Biopharmaceutical Products Growth	6.54%

Revenue by Geography

Financials in millions USD. Fiscal year is April - March.

Year Ending	Mar 31, 2024	Mar 31, 2023	Dec 31, 2021	Dec 31, 2020
China	85.19M
China Growth	6.54%